The ELLIPTA(®) Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers

Por Grant, Andrew C., Walker, Richard, Hamilton, Melanie, Garrill, Karl
Publicado no J Aerosol Med Pulm Drug Deliv (2015)

Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects

Por Allen, Ann, Bal, Joanne, Cheesbrough, Anne, Hamilton, Melanie, Kempsford, Rodger
Publicado em 2014

In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

Por Hamilton, Melanie, Leggett, Richard, Pang, Cheng, Charles, Stephen, Gillett, Ben, Prime, David
Publicado no J Aerosol Med Pulm Drug Deliv (2015)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5–11 Years with Persistent Asthma: A Randomized...

Por Oliver, Amanda, VanBuren, Sandi, Allen, Ann, Hamilton, Melanie, Tombs, Lee, Kempsford, Rodger, Qaqundah, Paul
Publicado no Clin Pharmacol Drug Dev (2014)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler

Por Prime, David, de Backer, Wilfried, Hamilton, Melanie, Cahn, Anthony, Preece, Andrew, Kelleher, Dennis, Baines, Amanda, Moore, Alison, Brealey, Noushin, Moynihan, Jackie
Publicado no J Aerosol Med Pulm Drug Deliv (2015)